MarkGarretMD

Neurology • Lebanon, NH

Neuromuscular Medicine

Assistant in Neurology, Massachusetts General Hospital Instructor, Harvard Medical School

Join to view full profile

Dr. Garret is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Garret's full profile

Already have an account?

Office
1 Medical Center Dr 1000
Lebanon, NH 03756
Phone+1 603-650-5000

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2020 - 2022
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2016 - 2020
Perelman School of Medicine at the University of PennsylvaniaClass of 2016

Certifications & Licensure

NH State Medical License 2024 - 2026
VT State Medical License 2024 - 2026
MA State Medical License 2022 - 2025
MO State Medical License 2016 - 2023
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electrodiagnostic MedicineBoard Certified, Electrodiagnostic Medicine

Clinical Trials

A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation Start of enrollment: 2021 May 17
Recruiting
Phase 3
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures Start of enrollment: 2021 Jan 01
Recruiting
Intermuscular Coherence as a Biomarker for ALS Start of enrollment: 2021 Mar 31
Recruiting
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS) Start of enrollment: 2024 May 30
Not yet recruiting
Phase 1, Phase 2
ASSESS ALL ALS Study
PREVENT ALL ALS Study
Join now to see all

Publications & Presentations

PubMed

1 citations
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
James D Berry, Sabrina Paganoni, Matthew B Harms, Neil Shneider, Jinsy Andrews
Muscle & Nerve. 2024-12-01
Body mass index is lower in asymptomaticexpansion carriers but not inpathogenic variant carriers compared to gene negatives.
Ikjae Lee, Mark A Garret, Joanne Wuu, Elizabeth A Harrington, James D Berry
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01
22 citations
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
Katherine E Irwin, Pei Jasin, Kerstin E Braunstein, Irika R Sinha, Mark A Garret
Nature Medicine. 2024-02-01

Professional Memberships